Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myasthenia gravis.

× No keyword cloud information.

63 in total

1. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

Authors: E Koustova; Y Sei; L Fossom; M L Wei; P N Usherwood; N B Keele; M A Rogawski; A S Basile
Journal: J Clin Invest Date: 2001-03 Impact factor: 14.808

2. Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.

Authors: M Bakhiet; L-Y Yu; V Ozenci; A Khan; F-D Shi
Journal: Clin Exp Immunol Date: 2006-05 Impact factor: 4.330

3. Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity.

Authors: Sue Stacy; Earlanda L Williams; Nathan E Standifer; Amanda Pasquali; Keith A Krolick; Anthony J Infante; Ellen Kraig
Journal: J Immunol Date: 2010-04-30 Impact factor: 5.422

4. Prevention of passively transferred experimental autoimmune myasthenia gravis by a phage library-derived cyclic peptide.

Authors: N Venkatesh; S H Im; M Balass; S Fuchs; E Katchalski-Katzir
Journal: Proc Natl Acad Sci U S A Date: 2000-01-18 Impact factor: 11.205

5. Detection of antibodies directed against the cytoplasmic region of the human acetylcholine receptor in sera from myasthenia gravis patients.

Authors: S J Tzartos; M Remoundos
Journal: Clin Exp Immunol Date: 1999-04 Impact factor: 4.330

6. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus.

Authors: P L Schwimmbeck; T Dyrberg; D B Drachman; M B Oldstone
Journal: J Clin Invest Date: 1989-10 Impact factor: 14.808

7. Inhibition of T-cell reactivity to myasthenogenic epitopes of the human acetylcholine receptor by synthetic analogs.

Authors: Y Katz-Levy; S L Kirshner; M Sela; E Mozes
Journal: Proc Natl Acad Sci U S A Date: 1993-08-01 Impact factor: 11.205

8. The nature of the active suppression of responses associated with experimental autoimmune myasthenia gravis by a dual altered peptide ligand administered by different routes.

Authors: M Paas-Rozner; M Sela; E Mozes
Journal: Proc Natl Acad Sci U S A Date: 2001-10-16 Impact factor: 11.205

9. Presentation of endogenous acetylcholine receptor antigen to a specific CD4+ T-cell line by a transfected B-cell line.

Authors: A F Mulcahy; D M Beeson; N Willcox; A G Diamond
Journal: Immunology Date: 1995-09 Impact factor: 7.397

10. Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopes.

Authors: A Faber-Elmann; M Paas-Rozner; M Sela; E Mozes
Journal: Proc Natl Acad Sci U S A Date: 1998-11-24 Impact factor: 11.205